PVantage™ Safety Data Automation
Pharmacovigilance Adverse Event Management Platform
PVantage is a modular offering, able to scale with your program as case volume increases.
PVantage™ is an innovative platform, that allows drug safety teams to streamline and automate case processing activities to ensure accuracy, efficiency, and compliance. This tool works with clinical trial and post market safety data and provides the ability to integrate, analyze, and visualize patient, program, and drug class information for greater control and oversight of your safety data.
PVantage is a proprietary cloud-based solution that allows Sponsors to elect the degree of automation of all workflows for case intake, case processing, safety data analysis and generation of standard reports. A dedicated, virtual managed environment provides Sponsors with a consistently updated platform and assures compliance with ever-changing global pharmacovigilance regulations.
Click to learn more about Comprehensive Safety Solutions to accompany this technology.
Case Intake Module
Allows for the automation and streamlining of case intake, including autopopulation of case data from a variety of sources
Data Integration Module
This module enables efficient and seamless data exchange between the Clinical electronic data capture (EDC) system and the Safety database, resulting in time reduction for case processing and data reconciliation while providing increases in quality.
Visualization of Safety Data Dashboards and Compliance Reports
PVantage dashboards allow for the visualization of complex safety data, making it easier to understand and interpret the data using a wide range of visualization options. The customizable data visualization layer allows for near real-time data inquiry and more informed decisions. In addition, sponsors can customize reporting content and cadence, including status reports, cumulative safety listings, KPIs, and other compliance reports.
With PVantage, Sponsors gain an accelerated technological advantage with greater visualization and efficient reporting of safety data.
Suggested For You
news
February 5th, 2026
MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions
perspectives
February 3rd, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development
news
January 29th, 2026
Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards
ebook
January 27th, 2026
A Practical Guide to Expedited Regulatory Pathways
perspectives
January 27th, 2026
What Regulators Want to See in Surrogate Endpoints Today
perspectives
January 20th, 2026
Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration
perspectives
January 13th, 2026
Making Clinical Trial Technology Work in Practice
fact sheet
December 17th, 2025
Advance Psychedelic Drug Development With Proven Regulatory and Data Expertise
fact sheet
December 17th, 2025
Agile Medical Writing Staff Augmentation When You Need Expertise Not Headcount
fact sheet
December 17th, 2025
Biometrics Solutions Fact Sheet: End-to-End Data Expertise for Complex Clinical Trials
whitepaper
December 17th, 2025
Estimands: Opportunity or Risk for Drug Developers?
perspectives
December 16th, 2025
Inside Pharma and Biotech’s Shifting Landscape and the Direction Leaders Are Giving for 2026